https://www.globenewswire.com/news-release/2017/08/31/1106085/0/en/Athenex-Pharmaceutical-Division-and-SunGen-Pharma-Announce-Terbutaline-Sulfate-Injection-Product-Launch.html
Athenex Pharmaceutical Division and SunGen Pharma Announce
BUFFALO, N.Y., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development...
pharmaceutical divisionannounce